Premium
Treatment of refractory bullous pemphigoid with IFN‐α‐2b: A case report
Author(s) -
Wang Tianjing,
Xu Yingping,
Ren Yingying,
Luo Guangpu
Publication year - 2019
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13080
Subject(s) - medicine , bullous pemphigoid , dermatology , refractory (planetary science) , pemphigoid , immunology , antibody , physics , astrobiology
We reported a patient with refractory bullous pemphigoid (BP), who had a higher level of eosinophils and serum IgE. The case showed less response to various therapies. Edematous erythema and new blisters appeared constantly. Considering IFN‐α‐2b treatment could significantly decrease blood eosinophils, we therefore expected that IFN‐α‐2b could be effective in the treatment of BP. After treated with IFN‐α‐2b, the patient's good response to the treatment suggested our hypothesis.